{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:18:38Z","timestamp":1790965118334,"version":"4.1.0"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T00:00:00Z","timestamp":1366243200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0061835","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T21:06:34Z","timestamp":1366319194000},"page":"e61835","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":208,"title":["Characteristic Cerebrospinal Fluid Cytokine\/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis"],"prefix":"10.1371","volume":"8","author":[{"given":"Takuya","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Yonekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Matsuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"DM Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"VA Lennon","year":"2004","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel","volume":"202","author":"VA Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"SF Roemer","year":"2007","journal-title":"Brain"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/ana.21802","article-title":"Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica","volume":"66","author":"JL Bennett","year":"2009","journal-title":"Ann Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","volume":"133","author":"S Saadoun","year":"2010","journal-title":"Brain"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1093\/brain\/awq177","article-title":"Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury","volume":"133","author":"R Marignier","year":"2010","journal-title":"Brain"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"M Bradl","year":"2009","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/1352458509104595","article-title":"Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese","volume":"15","author":"T Matsushita","year":"2009","journal-title":"Mult Scler"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"DM Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"ref11","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin-4 antibody status","author":"S* Yoshimura","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"CH Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"T Ishizu","year":"2005","journal-title":"Brain"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1212\/01.wnl.0000326589.57128.c3","article-title":"Distinct CSF cytokine\/chemokine profiles in atopic myelitis and other causes of myelitis","volume":"71","author":"M Tanaka","year":"2008","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jneuroim.2003.12.010","article-title":"CSF Chemokine levels in relapsing neuromyelitis optica and multiple sclerosis","volume":"149","author":"K Narikawa","year":"2004","journal-title":"J Neuroimmunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.0b013e3181c1deb9","article-title":"Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis","volume":"73","author":"K Yanagawa","year":"2009","journal-title":"Neurology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/1352458510379247","article-title":"Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6","volume":"16","author":"A Uzawa","year":"2010","journal-title":"Mult Scler"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","article-title":"Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages","volume":"6","author":"LE Harrington","year":"2005","journal-title":"Nat Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/ni1261","article-title":"A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17","volume":"6","author":"H Park","year":"2005","journal-title":"Nat Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1084\/jem.20030896","article-title":"Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation","volume":"198","author":"CA Murphy","year":"2003","journal-title":"J Exp Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"S Nakae","year":"2003","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1002\/eji.1830181122","article-title":"Excessive production of interleukin 6\/B cell stimulatory factor-2 in rheumatoid arthritis","volume":"18","author":"T Hirano","year":"1988","journal-title":"Eur J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/eji.1830200938","article-title":"Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells","volume":"20","author":"FM Brennan","year":"1990","journal-title":"Eur J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"S Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.4049\/jimmunol.164.5.2832","article-title":"High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism","volume":"164","author":"M Ziolkowska","year":"2000","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"SJ Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nm.2110","article-title":"T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis","volume":"16","author":"RC Axtell","year":"2010","journal-title":"Nat Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1177\/1352458512440060","article-title":"Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein","volume":"18","author":"K Herges","year":"2012","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination","volume":"252","author":"Y Warabi","year":"2007","journal-title":"J Neurol Sci"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/WNL.0b013e3181f8832e","article-title":"IFN\u03b2-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum","volume":"75","author":"J Shimizu","year":"2010","journal-title":"Neurology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1750-3639.2011.00475.x","article-title":"Reappraisal of aquaporin-4 astrocytopathy in Asian neuromyelitis optica and multiple sclerosis patients","volume":"21","author":"T Matsuoka","year":"2011","journal-title":"Brain Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/bjd.12070","article-title":"Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study","volume":"168","author":"P Rich","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjd.12110","article-title":"Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study","volume":"168","author":"KA Papp","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2133.2012.11099.x","article-title":"Psoriasis: Rationale for Targeting Interleukin-17","volume":"167","author":"G Girolomoni","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"CF Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1468-1331.2001.00327.x","article-title":"Chemokines CXCL10 and CCL2: differential involvement in intrathecal inflammation in multiple sclerosis","volume":"8","author":"TL S\u00f8rensen","year":"2001","journal-title":"Eur J Neurol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jns.2005.10.003","article-title":"IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis","volume":"241","author":"M Rentzos","year":"2006","journal-title":"J Neurol Sci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1002188","article-title":"Contribution of astrocyte-derived IL-15 to CD8 T cell effector functions in multiple sclerosis","volume":"185","author":"P Saikali","year":"2010","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneuroim.2007.12.004","article-title":"Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis","volume":"195","author":"J Correale","year":"2008","journal-title":"J Neuroimmunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"M Khademi","year":"2011","journal-title":"Mult Scler"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1351-5101.2003.00706.x","article-title":"Investigation of cytokine (tumor necrosis factor-alpha, interleukin-6, interleukin-10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus","volume":"11","author":"K Baraczka","year":"2004","journal-title":"Eur J Neurol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"P Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2249.2000.01334.x","article-title":"Macrophage inflammatory protein-1alpha (MIP-1\u03b1), MIP-1\u03b2, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions","volume":"122","author":"LA Boven","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-5728(97)00267-1","article-title":"Chemokines and chemotaxis of leukocytes in infectious meningitis","volume":"85","author":"F Lahrtz","year":"1998","journal-title":"J Neuroimmunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","article-title":"Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity","volume":"123","author":"J Antel","year":"2012","journal-title":"Acta Neuropathol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0061835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T07:27:37Z","timestamp":1715239657000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0061835"}},"subtitle":[],"editor":[{"given":"Akio","family":"Suzumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,18]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0061835","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,18]]}}}